73 employees
Xeltis is developing artificial vessels and valves that are gradually replaced by patients’ own living healthy tissue. www.xeltis.com
$14M sweet spot round size
2006
$14M
from 2 investors over 1 rounds
Xeltis raised $14M on September 14, 2023
Investors: European Innovation Council and + 5 Other investors